Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-01-01 @ 2:30 PM
Study NCT ID:
NCT00783367
Status:
COMPLETED
Last Update Posted:
2023-03-30
First Post:
2008-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2012-11-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-23
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-30
First Submit QC Date:
None
Study First Post Date:
2008-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-01
Results First Submit QC Date:
None
Results First Post Date:
2021-05-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-04-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-03-28
Last Update Post Date:
2023-03-30
Last Update Post Date Type:
ACTUAL